{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:04:48Z","timestamp":1794013488955,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.semarthrit.2022.152107","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T04:02:37Z","timestamp":1666065757000},"page":"152107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4601-4259","authenticated-orcid":false,"given":"Georgia","family":"Bentick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suba","family":"Nadesapillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Wicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-4361","authenticated-orcid":false,"given":"Jessica","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0001","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s40674-018-0110-6","article-title":"Myositis-related interstitial lung diseases: diagnostic features, treatment, and complications","volume":"5","author":"Shappley","year":"2019","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152107_bib0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-0039-1685187","article-title":"Lung diseases in inflammatory myopathies","volume":"40","author":"Barba","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0003","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"77","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152107_bib0004","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.7326\/0003-4819-134-12-200106190-00008","article-title":"Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study","volume":"134","author":"Buchbinder","year":"2001","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152107_bib0005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3899\/jrheum.140566","article-title":"Polymyositis\/dermatomyositis and malignancy risk: a metaanalysis study","volume":"42","author":"Yang","year":"2015","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152107_bib0006","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.rdc.2020.05.006","article-title":"Risk factors and cancer screening in myositis","volume":"46","author":"Moghadam-Kia","year":"2020","journal-title":"Rheum Dis Clin N Am"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152107_bib0007","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152107_bib0008","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/BOR.0000000000000535","article-title":"The diagnostic work-up of cancer-associated myositis","volume":"30","author":"Selva-O'Callaghan","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152107_bib0009","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2217\/iim.10.49","article-title":"Image reconstruction for PET\/CT scanners: past achievements and future challenges","volume":"2","author":"Tong","year":"2010","journal-title":"Imaging Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152107_bib0010","first-page":"4103","article-title":"Application of PET and PET\/CT imaging for cancer screening","volume":"24","author":"Chen","year":"2004","journal-title":"Anticancer Res"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152107_bib0011","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2967\/jnumed.112.105049","article-title":"Performance of whole-body PET\/CT for the detection of distant malignancies in various cancers: a systematic review and meta-analysis","volume":"53","author":"Xu","year":"2012","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152107_bib0012","first-page":"85","article-title":"Paraneoplastic syndromes: detection of malignant tumors using [18F]FDG-PET","volume":"47","author":"Berner","year":"2003","journal-title":"Q J Nucl Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152107_bib0013","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3899\/jrheum.111597","article-title":"Detection of inflammatory lesions by F-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis","volume":"39","author":"Owada","year":"2012","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s41824-020-00084-w","article-title":"18F-FDG PET\/CT in patients with polymyositis\/dermatomyositis: correlation with serum muscle enzymes","volume":"4","author":"Arai-Okuda","year":"2020","journal-title":"Eur J Hybrid Imaging"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152107_bib0015","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-017-3794-3","article-title":"Multiple values of 18F-FDG PET\/CT in idiopathic inflammatory myopathy","volume":"36","author":"Li","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152107_bib0016","doi-asserted-by":"crossref","first-page":"e03707","DOI":"10.1016\/j.heliyon.2020.e03707","article-title":"Value of (18)F-FDG PET\/CT in the detection of occult malignancy in patients with dermatomyositis","volume":"6","author":"Li","year":"2020","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0017","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13075-021-02578-9","article-title":"The lungs were on fire: a pilot study of 18F-FDG PET\/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease","volume":"23","author":"Liang","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152107_bib0018","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/MNM.0000000000000981","article-title":"18F-FDG PET\/CT versus conventional investigations for cancer screening in autoimmune inflammatory myopathy in the era of novel myopathy classifications","volume":"40","author":"Maliha","year":"2019","journal-title":"Nucl Med Commun"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152107_bib0019","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1007\/s00330-019-06302-9","article-title":"Clinical value of a [18F]-FDG PET-CT muscle-to-muscle SUV ratio for the diagnosis of active dermatomyositis","volume":"29","author":"Martis","year":"2019","journal-title":"Eur Radiol"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152107_bib0020","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/rheumatology\/kez040","article-title":"Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity","volume":"58","author":"Matuszak","year":"2019","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152107_bib0021","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1346-8138.14758","article-title":"Clinical value of 18F-fluorodeoxyglucose positron emission tomography\/computed tomography for interstitial lung disease and myositis in patients with dermatomyositis","volume":"46","author":"Motegi","year":"2019","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152107_bib0022","first-page":"570","article-title":"18F-fluorodeoxyglucose positron emission tomography for the assessment of myositis: a case series","volume":"30","author":"Pipitone","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152107_bib0023","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.amjmed.2009.11.012","article-title":"Conventional cancer screening versus PET\/CT in dermatomyositis\/polymyositis","volume":"123","author":"Selva-O'Callaghan","year":"2010","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152107_bib0024","first-page":"5023","article-title":"[18F]Fluorodeoxyglucose positron emission tomography\/computed tomography for diagnosing polymyositis\/dermatomyositis","volume":"15","author":"Sun","year":"2018","journal-title":"Exp Ther Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152107_bib0025","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1093\/rheumatology\/ket112","article-title":"[18F]FDG uptake in proximal muscles assessed by PET\/CT reflects both global and local muscular inflammation and provides useful information in the management of patients with polymyositis\/dermatomyositis","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0026","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006763","article-title":"Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation","volume":"5","author":"Tateyama","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2022.152107_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2021.12.008","article-title":"Cancer screening in idiopathic inflammatory myopathies: ten years experience from a single center","volume":"53","author":"Trallero-Aragu\u00e1s","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152107_bib0028","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1136\/annrheumdis-2018-214644","article-title":"Florbetapir positron emission tomography: identification of muscle amyloid in inclusion body myositis and differentiation from polymyositis","volume":"78","author":"Lilleker","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2022.152107_bib0029","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/jnnp.2009.197640","article-title":"Increased [11C]PIB-PET levels in inclusion body myositis are indicative of amyloid beta deposition","volume":"82","author":"Maetzler","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.semarthrit.2022.152107_bib0030","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3389\/fneur.2019.01386","article-title":"Diagnostic value of muscle [11C] PIB-PET in inclusion body myositis","volume":"10","author":"Noto","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152107_bib0040","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jos.2017.11.017","article-title":"Evaluation of muscle activity just after straight leg raising exercise by using (18)FDG-PET","volume":"23","author":"Shiozawa","year":"2018","journal-title":"J Orthop Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0031","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2967\/jnumed.108.054205","article-title":"18F-FDG PET and PET\/CT in the evaluation of cancer treatment response","volume":"50","author":"Ben-Haim","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semarthrit.2022.152107_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.745211","article-title":"Clinical value of (18)F-FDG PET\/CT scan and cytokine profiles in secondary hemophagocytic lymphohistiocytosis in idiopathic inflammatory myopathy patients: a pilot study","volume":"12","author":"Liang","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152107_bib0041","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/j.semnuclmed.2017.02.003","article-title":"FDG-PET\/CT in skeletal muscle: pitfalls and pathologies","volume":"47","author":"Parida","year":"2017","journal-title":"Semin Nucl Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152107_bib0032","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2004.12.011","article-title":"FDG-PET evaluation of vaginal carcinoma","volume":"62","author":"Lamoreaux","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152107_bib0033","doi-asserted-by":"crossref","first-page":"e94128","DOI":"10.1371\/journal.pone.0094128","article-title":"Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152107_bib0034","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keab166","article-title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","volume":"60","author":"Oldroyd","year":"2021","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152107_bib0035","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.lungcan.2012.10.018","article-title":"What causes false-negative PET findings for solid-type lung cancer?","volume":"79","author":"Iwano","year":"2013","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0036","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3348\/kjr.2006.7.1.57","article-title":"False positive and false negative FDG-PET scans in various thoracic diseases","volume":"7","author":"Chang","year":"2006","journal-title":"Korean J Radiol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152107_bib0037","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13244-010-0062-3","article-title":"Causes and imaging features of false positives and false negatives on F-PET\/CT in oncologic imaging","volume":"2","author":"Long","year":"2011","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0038","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/14397595.2015.1054099","article-title":"Deep-inspiration breath-hold 18F-FDG-PET\/CT is useful for assessment of connective tissue disease associated interstitial pneumonia","volume":"26","author":"Uehara","year":"2016","journal-title":"Mod Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152107_bib0039","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kez483","article-title":"The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients","volume":"59","author":"Peelen","year":"2020","journal-title":"Rheumatology"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152107_bib0042","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/acn3.50899","article-title":"18F-FDG uptake in denervated muscles of patients with peripheral nerve injury","volume":"6","author":"Choi","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.semarthrit.2022.152107_bib0043","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s41927-020-00146-3","article-title":"Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods - a qualitative study","volume":"4","author":"Oldroyd","year":"2020","journal-title":"BMC Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152107_bib0044","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nrrheum.2018.33","article-title":"Update on outcome assessment in myositis","volume":"14","author":"Rider","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152107_bib0045","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3389\/fneur.2019.00554","article-title":"Biomarkers in inflammatory myopathies-an expanded definition","volume":"10","author":"Benveniste","year":"2019","journal-title":"Front Neurol"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152107_bib0046","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","article-title":"Use of florbetapir-PET for imaging beta-amyloid pathology","volume":"305","author":"Clark","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152107_bib0047","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152107_bib0048","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41584-019-0223-9","article-title":"Amyloid-PET: a new tool for diagnosing IBM?","volume":"15","author":"Pinal-Fernandez","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152107_bib0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/rheumatology\/keab573","article-title":"Defining cardiac involvement in idiopathic inflammatory myopathies: a systematic review","volume":"61","author":"Fairley","year":"2022","journal-title":"Rheumatology"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222001585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:09:32Z","timestamp":1758733772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222001585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":50,"alternative-id":["S0049017222001585"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152107","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining the clinical utility of PET or PET-CT in idiopathic inflammatory myopathies: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152107"}}